Fred Andy Broadway III
2017
In 2017, Fred Andy Broadway III earned a total compensation of $683.5K as President, BioTel Heart at BioTelemetry, a 9% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $189,375 |
---|---|
Option Awards | $93,827 |
Salary | $301,981 |
Stock Awards | $87,310 |
Other | $11,002 |
Total | $683,495 |
Broadway received $302K in salary, accounting for 44% of the total pay in 2017.
Broadway also received $189.4K in non-equity incentive plan, $93.8K in option awards, $87.3K in stock awards and $11K in other compensation.
Rankings
In 2017, Fred Andy Broadway III's compensation ranked 10,715th out of 14,666 executives tracked by ExecPay. In other words, Broadway earned more than 26.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,715 out of 14,666 | 27th |
Division Services | 1,828 out of 2,424 | 25th |
Major group Health Services | 186 out of 224 | 17th |
Industry group Miscellaneous Health And Allied Services, Not | 27 out of 34 | 21st |
Industry Specialty Outpatient Facilities, Not Elsewhere Classified | 13 out of 13 | 0th |
Source: SEC filing on March 22, 2018.
Broadway's colleagues
We found four more compensation records of executives who worked with Fred Andy Broadway III at BioTelemetry in 2017.